Search research articles
Contact Us
Filters
Showing results (501-510 of 1,726) with videos related to
Page
of 173
Sort By:
Learning & Memory (Cold Spring Harbor, N.Y.)
|
August 26, 2010
The sensitivity of memory consolidation and reconsolidation to inhibitors of protein synthesis and kinases: computational analysis
Yili Zhang, Paul Smolen, Douglas A Baxter, et al.
AJS; American Journal of Sociology
|
July 3, 2009
Environmental contingencies and genetic propensities: social capital, educational continuation, and dopamine receptor gene DRD2
Michael J Shanahan, Stephen Vaisey, Lance D Erickson, et al.
British Journal of Rheumatology
|
July 3, 1998
Two different drug-induced pulmonary complications in a patient suffering from rheumatoid arthritis
B F Leeb, C Scheinecker, H Schweitzer, et al.
The Lancet. Oncology
|
November 8, 2016
Safety and efficacy of biosimilars in oncology
Huub Schellekens, Josef S Smolen, Mario Dicato, et al.
Eneuro
|
February 16, 2017
Biphasic Regulation of p38 MAPK by Serotonin Contributes to the Efficacy of Stimulus Protocols That Induce Long-Term Synaptic Facilitation
Yili Zhang, Paul Smolen, Douglas A Baxter, et al.
Arthritis and Rheumatism
|
June 1, 1995
Diagnostic use of office-based ultrasound. Baker's cyst of the right knee joint
B F Leeb, I Stenzel, H Czembirek, et al.
International Journal of Experimental Pathology
|
August 1, 1994
Infection of human monocytes by Leishmania results in a defective oxidative burst
J H Passwell, R Shor, J Smolen, et al.
Neuroimage
|
February 2, 2010
Reward circuitry responsivity to food predicts future increases in body mass: moderating effects of DRD2 and DRD4
Eric Stice, Sonja Yokum, Cara Bohon, et al.
Nature Reviews. Rheumatology
|
March 25, 2015
Clocking in: chronobiology in rheumatoid arthritis
Frank Buttgereit, Josef S Smolen, Andrew N Coogan, et al.
Annals of the Rheumatic Diseases
|
August 2, 2020
Response to: 'Comment on 'Implication of baseline levels and early changes of C-reactive protein for subsequent clinical outcomes of patients with rheumatoid arthritis treated with tocilizumab'' by Pethoe-Schramm <i>et al</i>
Inbal Haya Shafran, Farideh Alasti, Josef S Smolen, et al.
Page
of 173
Search research articles
Search
Showing results (501-510 of 1,726) with videos related to
Sort By:
Page
of 173
Learning & Memory (Cold Spring Harbor, N.Y.)
|
August 26, 2010
The sensitivity of memory consolidation and reconsolidation to inhibitors of protein synthesis and kinases: computational analysis
Yili Zhang, Paul Smolen, Douglas A Baxter, et al.
AJS; American Journal of Sociology
|
July 3, 2009
Environmental contingencies and genetic propensities: social capital, educational continuation, and dopamine receptor gene DRD2
Michael J Shanahan, Stephen Vaisey, Lance D Erickson, et al.
British Journal of Rheumatology
|
July 3, 1998
Two different drug-induced pulmonary complications in a patient suffering from rheumatoid arthritis
B F Leeb, C Scheinecker, H Schweitzer, et al.
The Lancet. Oncology
|
November 8, 2016
Safety and efficacy of biosimilars in oncology
Huub Schellekens, Josef S Smolen, Mario Dicato, et al.
Eneuro
|
February 16, 2017
Biphasic Regulation of p38 MAPK by Serotonin Contributes to the Efficacy of Stimulus Protocols That Induce Long-Term Synaptic Facilitation
Yili Zhang, Paul Smolen, Douglas A Baxter, et al.
Arthritis and Rheumatism
|
June 1, 1995
Diagnostic use of office-based ultrasound. Baker's cyst of the right knee joint
B F Leeb, I Stenzel, H Czembirek, et al.
International Journal of Experimental Pathology
|
August 1, 1994
Infection of human monocytes by Leishmania results in a defective oxidative burst
J H Passwell, R Shor, J Smolen, et al.
Neuroimage
|
February 2, 2010
Reward circuitry responsivity to food predicts future increases in body mass: moderating effects of DRD2 and DRD4
Eric Stice, Sonja Yokum, Cara Bohon, et al.
Nature Reviews. Rheumatology
|
March 25, 2015
Clocking in: chronobiology in rheumatoid arthritis
Frank Buttgereit, Josef S Smolen, Andrew N Coogan, et al.
Annals of the Rheumatic Diseases
|
August 2, 2020
Response to: 'Comment on 'Implication of baseline levels and early changes of C-reactive protein for subsequent clinical outcomes of patients with rheumatoid arthritis treated with tocilizumab'' by Pethoe-Schramm <i>et al</i>
Inbal Haya Shafran, Farideh Alasti, Josef S Smolen, et al.
Page
of 173